Private Equity

Updated:

Research Bridge Partners

A non-profit that enhances the societal and economic returns on America's investment in research universities by bridging heartland university researchers...

Research Bridge Partners logo

Research Bridge Partners

A non-profit that enhances the societal and economic returns on America's investment in research universities by bridging heartland university researchers and startup resources nationally.

General information

Firm type

Private Equity

Year founded

2016

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Dallas

Corporate office

Dallas, TX, United States

Principals

Isaac Barchas

Co-Founder

Reid Hoffman

Co-Founder

Sector focus

Digital HealthHealthcare Services

Frequently asked questions

Who runs investment decisions at Research Bridge Partners?

Isaac Barchas and Reid Hoffman co-founded the firm and serve as founding board members, with Barchas bringing deep experience from leading the University of Texas at Austin's technology incubator. The operating team combines translational research, venture capital, and data analytics backgrounds. Specific investment committee composition or delegated authorities are not publicly detailed.

How does Research Bridge Partners source proprietary deal flow?

The firm uses proprietary analytics to identify academic researchers nationwide whose science and entrepreneurial profiles match those of successful biomedical startup founders. It also relies on longstanding relationships with specific mid-continent research institutions. This method targets high-quality science in geographies with thinner commercialization resources, where many investment opportunities the firm believes are overlooked.

Is Research Bridge Partners structured as a single family office or does it operate more like a venture firm?

It operates as a non-profit asset manager that makes formative investments in biomedical startups. It is not a family office. The firm runs both tax-exempt and for-profit funds that complement each other: the non-profit arm seeds companies when commercial capital is unavailable, and the for-profit arm attracts institutional and family-office capital for later-stage development.

Does Research Bridge Partners participate in fund commitments or only direct deals?

The firm's described model centers on direct, formative investments in startup companies built around specific university research. It does not publicly describe making fund commitments to other venture capital firms. The for-profit fund is structured to attract co-investment from downstream investors rather than allocate capital as a limited partner.

What investment stages does Research Bridge Partners typically target?

The firm initiates seed investments and continues through pre-clinical and early clinical development. It begins by validating and protecting intellectual property, establishing governance, and then developing capitalization strategies based on the IP's value. The focus is on the earliest stages where commercial capital is often absent.

Which sectors does Research Bridge Partners explicitly avoid?

The firm's public materials focus exclusively on biomedical startups. There is no indication it invests outside life sciences, health tech, or healthcare services. It does not mention digital health outside a biomedical context, nor does it reference any activity in software, physical sciences, or other non-biomedical university research.

How is Research Bridge Partners related to Reid Hoffman's other ventures?

Reid Hoffman co-founded the firm with Isaac Barchas and serves on its founding board, but Research Bridge Partners operates as an independent non-profit entity separate from Hoffman's venture capital activities at Greylock or his other philanthropic work. The firm's structure and mission are specific to bridging midcontinent university research and biomedical commercialization.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Dallas Private Equity profiles